[Delayed appearance of symptoms in immediate hypersensitivity: type I sensitization to galactose-α-1,3-galactose]. (Q50511429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

[Delayed appearance of symptoms in immediate hypersensitivity: type I sensitization to galactose-α-1,3-galactose] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

M Röcken

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

German

0 references

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

63 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

76-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

A unique natural human IgG antibody with anti-alpha-galactosyl specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

Cat IgA, representative of new carbohydrate cross-reactive allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

The carbohydrate galactose-alpha-1,3-galactose is a major IgE-binding epitope on cat IgA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-011-2299-2

High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history

21 January 2018

1 reference

12 December 2020

[Exertion-induced anaphylaxis after eating pork and beef]

1 reference

12 December 2020

Complete structure of the carbohydrate moiety of stem bromelain. An application of the almond glycopeptidase for structural studies of glycopeptides

1 reference

12 December 2020

Value of component based diagnostics in IgE-mediated hymenoptera sting reactions.

1 reference

12 December 2020

10.1007/S00105-011-2299-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543951%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference